[en] The mammalian heart expresses all three isoforms of nitric oxide synthases (NOS) in diverse cell types of the myocardium. Despite their apparent promiscuity, the NOS isoforms support specific signaling because of their subcellular compartmentation with colocalized effectors and limited diffusibility of NO in muscle cells. eNOS and nNOS sustain normal EC coupling and contribute to the early and late phases of the Frank-Starling mechanism of the heart. They also attenuate the beta1-/beta2-adrenergic increase in inotropy and chronotropy, and reinforce the pre- and post-synaptic vagal control of cardiac contraction. By doing so, the NOS protect the heart against excessive stimulation by catecholamines, just as an "endogenous beta-blocker". In the ischemic and failing myocardium, induced iNOS further reinforces this effect, as does eNOS coupled to overexpressed beta3-adrenoceptors. nNOS expression also increases in the aging and infarcted heart, but its role (compensatory or deleterious) is less clear. In addition to their direct regulation of contractility, the NOS modulate oxygen consumption, substrate utilization, sensitivity to apoptosis, hypertrophy and regenerative potential, all of which illustrate the pleiotropic effects of this radical on the cardiac cell biology.
Disciplines :
Anesthesia & intensive care
Author, co-author :
MASSION, Paul ; Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs
Pelat, Michel
Belge, C.
Balligand, J.-L.
Language :
English
Title :
Regulation of the mammalian heart function by nitric oxide.
Publication date :
2005
Journal title :
Comparative Biochemistry and Physiology. Part A, Molecular and Integrative Physiology
ISSN :
1095-6433
eISSN :
1531-4332
Publisher :
Elsevier Science, New York, United States - New York
A. Adler, H. Huang, Z. Wang, J. Conetta, E. Levee, X. Zhang, and T.H. Hintze Endocardial endothelium in the avascular frog heart: role for diffusion of NO in control of cardiac O2 consumption Am. J. Physiol., Heart Circ. Physiol. 287 2004 H14 H21
P. Andreka, Z. Nadhazi, G. Muzes, G. Szantho, L. Vandor, L. Konya, M.S. Turner, Z. Tulassay, and N.H. Bishopric Possible therapeutic targets in cardiac myocyte apoptosis Curr. Pharm. Des. 10 2004 2445 2461
M.A. Arstall, D.B. Sawyer, R. Fukazawa, and R.A. Kelly Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation Circ. Res. 85 1999 829 840
E.A. Ashley, C.E. Sears, S.M. Bryant, H.C. Watkins, and B. Casadei Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes Circulation 105 2002 3011 3016
J.L. Balligand, R.A. Kelly, P.A. Marsden, T.W. Smith, and T. Michel Control of cardiac muscle cell function by an endogenous nitric oxide signaling system Proc. Natl. Acad. Sci. U. S. A. 90 1993 347 351
J.L. Balligand, D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T.W. Smith Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium J. Clin. Invest. 91 1993 2314 2319
R. Bolli Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research J. Mol. Cell. Cardiol. 33 2001 1897 1918
J.M. Canty Jr. Nitric oxide and short-term hibernation: friend or foe? Circ. Res. 87 2000 85 87
T. Damy, P. Ratajczak, A.M. Shah, E. Camors, I. Marty, G. Hasenfuss, F. Marotte, J.L. Samuel, and C. Heymes Increased neuronal nitric oxide synthase-derived NO production in the failing human heart Lancet 363 2004 1365 1367
C. Dessy, R.A. Kelly, J.L. Balligand, and O. Feron Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling EMBO J. 19 2000 4272 4280
S.L. Elfering, T.M. Sarkela, and C. Giulivi Biochemistry of mitochondrial nitric-oxide synthase J. Biol. Chem. 277 2002 38079 38086
O. Feron, T.W. Smith, T. Michel, and R.A. Kelly Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes J. Biol. Chem. 272 1997 17744 17748
O. Feron, F. Saldana, J.B. Michel, and T. Michel The endothelial nitric-oxide synthase-caveolin regulatory cycle J. Biol. Chem. 273 1998 3125 3128
O. Feron, C. Dessy, S. Moniotte, J.P. Desager, and J.L. Balligand Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase J. Clin. Invest. 103 1999 897 905
U. Flogel, M.W. Merx, A. Godecke, U.K. Decking, and J. Schrader Myoglobin: a scavenger of bioactive NO Proc. Natl. Acad. Sci. U. S. A. 98 2001 735 740
U. Forstermann, J.P. Boissel, and H. Kleinert Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J. 12 1998 773 790
C. Gauthier, V. Leblais, L. Kobzik, J.N. Trochu, N. Khandoudi, A. Bril, J.L. Balligand, and H. Le Marec The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle J. Clin. Invest. 102 1998 1377 1384
R.J. Gryglewski, R.M. Palmer, and S. Moncada Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor Nature 320 1986 454 456
J.M. Hare Spatial confinement of isoforms of cardiac nitric-oxide synthase: unravelling the complexities of nitric oxide's cardiobiology Lancet 363 2004 1338 1339
J.M. Hare, and J.S. Stamler NO/redox disequilibrium in the failing heart and cardiovascular system J. Clin. Invest. 115 2005 509 517
N. Herring, and D.J. Paterson Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro J. Physiol. 535 2001 507 518
S. Janssens, P. Pokreisz, L. Schoonjans, M. Pellens, P. Vermeersch, M. Tjwa, P. Jans, M. Scherrer-Crosbie, M.H. Picard, Z. Szelid, H. Gillijns, F. Van de Werf, D. Collen, and K.D. Bloch Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction Circ. Res. 94 2004 1256 1262
F. Jung, L.A. Palmer, N. Zhou, and R.A. Johns Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes Circ. Res. 86 2000 319 325
S. Kanno, P.K. Kim, K. Sallam, J. Lei, T.R. Billiar, and L.L. Shears Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 12277 12281
S.A. Khan, M.W. Skaf, R.W. Harrison, K. Lee, K.M. Minhas, A. Kumar, M. Fradley, A.A. Shoukas, D.E. Berkowitz, and J.M. Hare Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases Circ. Res. 92 2003 1322 1329
H. Kleinert, P.M. Schwarz, and U. Forstermann Regulation of the expression of inducible nitric oxide synthase Biol. Chem. 384 2003 1343 1364
B.C. Kone, T. Kuncewicz, W. Zhang, and Z.Y. Yu Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide Am. J. Physiol., Renal. Physiol. 285 2003 F178 F190
K.E. Loke, P.I. McConnell, J.M. Tuzman, E.G. Shesely, C.J. Smith, C.J. Stackpole, C.I. Thompson, G. Kaley, M.S. Wolin, and T.H. Hintze Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption Circ. Res. 84 1999 840 845
P.B. Massion, O. Feron, C. Dessy, and J.L. Balligand Nitric oxide and cardiac function: ten years after, and continuing Circ. Res. 93 2003 388 398
P.B. Massion, C. Dessy, F. Desjardins, M. Pelat, X. Havaux, C. Belge, P. Moulin, Y. Guiot, O. Feron, S. Janssens, and J.L. Balligand Cardiomyocyte- restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates b-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction Circulation 110 2004 2666 2672
R.M. Mohan, D.A. Heaton, E.J. Danson, S.P. Krishnan, S. Cai, K.M. Channon, and D.J. Paterson Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function Circ. Res. 91 2002 1089 1091
S. Moniotte, L. Kobzik, O. Feron, J.N. Trochu, and C. Gauthier Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium Circulation 103 2001 1649 1655
C.R. Nishida, and P.R. Ortiz de Montellano Electron transfer and catalytic activity of nitric oxide synthases. Chimeric constructs of the neuronal, inducible, and endothelial isoforms J. Biol. Chem. 273 1998 5566 5571
M.G. Petroff, S.H. Kim, S. Pepe, C. Dessy, E. Marban, J.L. Balligand, and S.J. Sollott Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes Nat. Cell Biol. 3 2001 867 873
B.D. Prendergast, V.F. Sagach, and A.M. Shah Basal release of nitric oxide augments the Frank-Starling response in the isolated heart Circulation 96 1997 1320 1329
F.A. Recchia Role of nitric oxide in the regulation of substrate metabolism in heart failure Heart Fail. Rev. 7 2002 141 148
A. Rengasamy, and R.A. Johns Determination of Km for oxygen of nitric oxide synthase isoforms J. Pharmacol. Exp. Ther. 276 1996 30 33
W.F. Saavedra, N. Paolocci, M.E. St. John, M.W. Skaf, G.C. Stewart, J.S. Xie, R.W. Harrison, J. Zeichner, D. Mudrick, E. Marban, D.A. Kass, and J.M. Hare Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart Circ. Res. 90 2002 297 304
C.E. Sears, S.M. Bryant, E.A. Ashley, C.A. Lygate, S. Rakovic, H.L. Wallis, S. Neubauer, D.A. Terrar, and B. Casadei Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling Circ. Res. 92 2003 e52 e59
P. Sonveaux, P. Martinive, J. Dewever, Z. Batova, G. Daneau, M. Pelat, P. Ghisdal, V. Gregoire, C. Dessy, J.L. Balligand, and O. Feron Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis Circ. Res. 95 2004 154 161
C. Stefanelli, C. Pignatti, B. Tantini, I. Stanic, F. Bonavita, C. Muscari, C. Guarnieri, C. Clo, and C.M. Caldarera Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes Biochim. Biophys. Acta 1450 1999 406 413
N. Suto, A. Mikuniya, T. Okubo, H. Hanada, N. Shinozaki, and K. Okumura Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency Am. J. Physiol. 275 1998 H41 H49
H. Tada, C.I. Thompson, F.A. Recchia, K.E. Loke, M. Ochoa, C.J. Smith, E.G. Shesely, G. Kaley, and T.H. Hintze Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart Circ. Res. 86 2000 270 274
Y. Takimoto, T. Aoyama, K. Tanaka, R. Keyamura, Y. Yui, and S. Sasayama Augmented expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats Circulation 105 2002 490 496
E. Takimoto, H.C. Champion, M. Li, S. Ren, E.R. Rodriguez, B. Tavazzi, G. Lazzarino, N. Paolocci, K.L. Gabrielson, Y. Wang, and D.A. Kass Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load J. Clin. Invest. 115 2005 1221 1231
J.N. Trochu, J.B. Bouhour, G. Kaley, and T.H. Hintze Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease Circ. Res. 87 2000 1108 1117
C. Wunderlich, U. Flogel, A. Godecke, J. Heger, and J. Schrader Acute inhibition of myoglobin impairs contractility and energy state of iNOS-overexpressing hearts Circ. Res. 92 2003 1352 1358
M.T. Ziolo, and D.M. Bers The real estate of NOS signaling: location, location, location Circ. Res. 92 2003 1279 1281
M.T. Ziolo, H. Katoh, and D.M. Bers Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes Circulation 104 2001 2961 2966
M.T. Ziolo, L.S. Maier, V. Piacentino III, J. Bossuyt, S.R. Houser, and D.M. Bers Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients Circulation 109 2004 1886 1891